Pekin Hardy Strauss, Inc. Astrazeneca PLC Transaction History
Pekin Hardy Strauss, Inc.
- $744 Million
- Q4 2024
A detailed history of Pekin Hardy Strauss, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 5,800 shares of AZN stock, worth $411,452. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,800Holding current value
$411,452% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,336Shares Held
477MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.46 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.98 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.64 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.61 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...